A risk-adjusted definition of biochemical recurrence after radical prostatectomy.

about

Adjuvant Versus Early Salvage Radiation Therapy Following Radical Prostatectomy for Men with Localized Prostate Cancer.Stratification model based on early postprostatectomy prostate-specific antigen kinetics may help to reduce the risk of overtreatment in candidates for adjuvant radiotherapy.

P2860

Q39356227-A6F4D54C-0D09-48B7-AB26-BF784C4FFE42 Q47794052-D4B88F67-B330-40E9-A12A-0D7B26B5DA43

P2860

A risk-adjusted definition of biochemical recurrence after radical prostatectomy.

Item

http://www.wikidata.org/entity/Q39234684

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

A risk-adjusted definition of biochemical recurrence after radical prostatectomy.

@en

A risk-adjusted definition of biochemical recurrence after radical prostatectomy.

@nl

type

Item

label

A risk-adjusted definition of biochemical recurrence after radical prostatectomy.

@en

A risk-adjusted definition of biochemical recurrence after radical prostatectomy.

@nl

prefLabel

A risk-adjusted definition of biochemical recurrence after radical prostatectomy.

@en

A risk-adjusted definition of biochemical recurrence after radical prostatectomy.

@nl

P1476

A risk-adjusted definition of biochemical recurrence after radical prostatectomy.

@en

P2093

D W Lin

http://www.w3.org/2001/XMLSchema#string

J E Cowan

http://www.w3.org/2001/XMLSchema#string

M V Meng

http://www.w3.org/2001/XMLSchema#string

P R Carroll

http://www.w3.org/2001/XMLSchema#string

T M Morgan

http://www.w3.org/2001/XMLSchema#string

V Weinberg

http://www.w3.org/2001/XMLSchema#string

P2860

Natural history of progression after PSA elevation following radical prostatectomy.

Prognostic implications of an undetectable ultrasensitive prostate-specific antigen level after radical prostatectomy

Defining the ideal cutpoint for determining PSA recurrence after radical prostatectomy. Prostate-specific antigen.

Endpoints in prostate cancer clinical trials.

The CAPRA-S score: A straightforward tool for improved prediction of outcomes after radical prostatectomy.

Cancer and Leukemia Group B (CALGB) 90203: a randomized phase 3 study of radical prostatectomy alone versus estramustine and docetaxel before radical prostatectomy for patients with high-risk localized disease.

The contemporary management of prostate cancer in the United States: lessons from the cancer of the prostate strategic urologic research endeavor (CapSURE), a national disease registry.

Salvage radiotherapy for recurrent prostate cancer after radical prostatectomy.

Veterans Affairs Cooperative Studies Program study 553: Chemotherapy after prostatectomy, a phase III randomized study of prostatectomy versus prostatectomy with adjuvant docetaxel for patients with high-risk, localized prostate cancer.

Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy.

P2888

pcan.2014.5

P304

174-179

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/PCAN.2014.5

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Matthew R Cooperberg

P577

2014-03-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24614692

http://www.w3.org/2001/XMLSchema#string

A risk-adjusted definition of biochemical recurrence after radical prostatectomy.

about

P2860

P2860

A risk-adjusted definition of biochemical recurrence after radical prostatectomy.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698